Our Boston injury attorneys know a products liability lawsuit may involve multiple defendants who participated in the manufacture, advertising, distribution, and retail sale of the medication. Hardin v. PDX, Inc., an opinion from the California Court of Appeals, involved a plaintiff who experienced a complete and permanent loss of eyesight,…
Our Boston injury lawyers understand that no patient can make an informed consent about the risks they face in taking a medication if they are not told of known side effects. A recent article in the La Crosse Tribune discusses the ongoing lawsuit by NFL players against the NFL organization…
Despite ongoing litigation surrounding the diabetes drug Actos, the Japanese drug manufacturer, Takeda Pharmaceutical Co Ltd, seems to be pushing ahead with sales and conducting studies to find new markets for its medication. According to a recent article from Reuters, a German study shows Actos may delay the onset of…
Our Boston personal injury lawyers who represent patients with knee replacement-related injuries know that these matters can be confusing to patients who may already have been the victim of inappropriate medical advice. A new report from CBS examines whether doctors are performing more knee replacements than are medically necessary. A…
Our Boston hip replacement attorneys understand that representing a client injured by one of the now-recalled DePuy artificial hips requires a great deal of familiarity with defective medical product litigation. These can be extremely complicated cases. According to a recent article, the State of Oregon has settled with DePuy Orthopedics…
Our Boston testosterone replacement lawyers have been closely following recent FDA action involving the risks associated with TRT. Now, Live Science is taking a look at whether the many benefits claimed by testosterone replacement therapy manufacturers are supported by study results. Drug manufacturers have claimed that testosterone replacement therapy can…
The Food and Drug Administration has issued a new warning this June about certain over-the-counter acne medications. According to an FDA Consumer Update alert, some patients have reported serious and potentially life-threatening reactions after using acne products. Patients who use over-the-counter acne products should review the FDA information carefully to…
The Food and Drug Administration has received numerous reports of blood clots in the veins of patients taking testosterone therapy products. In response to these reports and increasing concerns about the risks associated with testosterone therapy, the FDA announced that the products must update their warning label to alert patients…
In the wake of a $9 billion verdict against Japanese drugmaker Takeda Pharmaceuticals, the manufacturer of diabetes drug Actos, which has been causally connected to instances of bladder cancer, the number of lawsuits filed against the firm continues. Boston Actos injury attorneys recognize that in reality, that $9 billion will…
When the Food and Drug Administration (FDA) grants approval for the release of a drug, the medication is intended for use only for a specific purpose. For example, an antidepressant medication would be tested on patients suffering from depression and the drug is thus approved only for the treatment of…